期刊文献+

化疗药物阿霉素靶向治疗肝癌的研究进展 被引量:3

Research progress of adriamycin in targeted therapy for liver carcinoma
原文传递
导出
摘要 靶向治疗是增加化疗药物疗效并减少其不良反应的重要途径之一,选择靶向药物载体系统非常重要.阿霉素在肝癌的靶向治疗中具有重要作用,阿霉素载体系统通过不同的作用机制靶向治疗肝癌,抑制和杀伤肿瘤细胞,降低了化疗药物的不良反应.文章对阿霉素靶向治疗肝癌的给药方式、药物载体和提高疗效的方式进行阐述,并对其他化疗药物及载体靶向治疗肝癌的作用进行了介绍,综述阿霉素在肝癌靶向治疗中的研究进展. Targeted cancer therapy is one of the modalities to increase efficiency and decrease adverse effects of chemotherapy,and the selection of drug vector system is of importance for targeted therapy.An ideal adriamycin targeted vector system should have maximal efficacy and minimal adverse effects in inhibiting cancer cells through different mechanisms.This article reviews the recent progress in adriamycin targeted therapy,including the modes of adriamycin administration,the selection of drug vectors,as well as other chemotherapeutic drugs in targeted therapy of liver carcinoma.
出处 《中华全科医师杂志》 2016年第6期482-485,共4页 Chinese Journal of General Practitioners
关键词 肝肿瘤 阿霉素 靶向治疗 Liver neoplasms Adriamycin Cancer-targeted therapy
  • 相关文献

参考文献38

  • 1Thiele M, Gluud LL, Fialla AD, et al. Large variations in risk of hepatocellular carcinoma and mortality in treatment naive hepatitis B patients: systematic review with meta-analyses[ J]. PLoS One, 2014, 9 (9) : e107177. DOI : 10. 1371/journal. pone. 0107177.
  • 2Yang J, Yan L, Wang W. Current status of multimodal & combination therapy for hepatoeellular carcinoma [ J]. Indian J Med Res, 2012,136(3) : 391-403.
  • 3Cervello M, MeCubrey JA, Cusimano A, et al. Targeted therapy for hepatocellular carcinoma : novel agents on the horizon [ J ]. Oncotarget, 2012, 3(3): 236-260.
  • 4Li H, Zhou S, Li T, et al. Suppression of BCRP expression and restoration of sensitivity to chemotherapy in muhidrug-resistant HCC cell line HEPG2/ADM by RNA interference [ J ]. Hepatogastroenterology, 2012, 59 (119) : 2238-2242. DOI : 10. 5754/hge11781.
  • 5郭予武.肝动脉栓塞化疗术联合小分子靶向治疗晚期肝癌临床疗效观察[J].中国医学工程,2012,20(6):11-13. 被引量:9
  • 6Wong R, Frenette. Updates in the management of hepatocellular carcinoma[ J]. Gastroenterol Hepatol ( N Y) , 2011,7 ( 1 ) : 16- 24.
  • 7Deshpande PP, Biswas S, Torchilin VP. Current trends in the use of liposomes for tumor targeting [ J ]. Nanomedicine ( Lond ), 2013,8(9) : 1509-1525. DOI: 10.2217/nnm. 13. 118.
  • 8张盈,杨硕,李灵芝.肝靶向给药体系研究进展[J].中国新药杂志,2013,22(8):923-927. 被引量:11
  • 9张洪新,郭卫平,王执民,王义清,刘燕,高巍,李文献,倪代慧,梁志会,曹伟,关彦.阿霉素化疗与热化疗对人肝癌细胞耐药模型作用的比较[J].第四军医大学学报,2000,21(8):964-967. 被引量:5
  • 10Jeon M J, Ahn CH, Kim H, et al. The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthennia combined with pharmacotherapy in a hepatocellular carcinoma model [ J ]. J Exp Clin Cancer Res, 2014, 33:57. DOI: 10. 1186/s13046-014-0057-x.

二级参考文献235

共引文献72

同被引文献26

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部